Bilski, Adam

Chalubinska, Justyna

Fendler, Wojciech

Jeziorski, Arkadiusz

Kubiak, Robert

Pasz-Walczak, Grażyna

Piekarska, Anna

Piekarski, Janusz

Pluta, Piotr

Potemski, Piotr

Sek, Piotr

Wronski, Konrad

Archives of Medical Science

English

PubMed

Adam Bilski

Grażyna Pasz-Walczak

Robert Kubiak

Piotr Sek

Justyna Chalubinska

Wojciech Fendler

Konrad Wronski

Anna Piekarska

Piotr Pluta

Piotr Potemski

Arkadiusz Jeziorski

Janusz Piekarski

Crossref

TRAIL protein expression in breast cancer cells correlates with nuclear grade

Adenoviral-mediated transfer of the TNF-related apoptosis-inducing ligand/Apo-2 ligand gene induces tumor cell apoptosis.

Antitumor activity of a novel recombinant mutant human tumor necrosis factor-related apoptosis-inducing ligand. Acta Pharmacol Sin

Assessment of histological grade.

Association between up-regulation of Fas ligand expression and apoptosis of tumor-infiltrating lymphocytes in human breast cancer.

Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family.

Control of TRAILinduced apoptosis by a family of signaling and decoy receptors. Science

Differential expression of TRAIL and its receptors in benign and malignant prostate tissues.

Expression of Fas (CD95/APO-1) ligand by human breast cancers: significance for tumor immune privilege. Clin Diagn Lab Immunol

Expression of osteoprotegerin (OPG), TNF related apoptosis inducing ligand (TRAIL), and receptor activator of nuclear factor kappaB ligand (RANKL) in human breast tumours.

Expression of the apoptosis-inducing ligands FasL and TRAIL in malignant and benign human breast tumors. Histochem Cell Biol

Expression of TNF-related apoptosis-inducing ligand (TRAIL) and its receptors in gastric carcinoma and tumor-infiltrating lymphocytes: a possible mechanism of immune evasion of the tumor.

Expression of TRAIL (TNF-related apoptosis-inducing ligand) and its receptors in normal colonic mucosa, adenomas, and carcinomas.

Expression of TRAIL and TRAIL death receptors in stage III non-small cell lung cancer tumors. Clin Cancer Res

Expression of tumour necrosis factor-related apoptosis-inducing ligand death receptors in sporadic and hereditary colorectal tumours: potential targets for apoptosis induction.

FAS and FAS-L expression by tumor cells and lymphocytes in breast carcinomas and their lymph node metastases. Pathol Res Pract

Functional expression of tumor necrosis factor-related apoptosisinducing ligand in human colonic adenocarcinoma cells. Lab Invest

Histological expression of tumour necrosis factor-related apoptosisinducing ligand (TRAIL) in human primary melanoma. Pathology

Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity

Involvement of TNF-related apoptosis-inducing ligand (TRAIL) induction in interferon gamma-mediated apoptosis in Ewing tumor cells.

McCarty KS Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch Pathol Lab Med

Mechanisms and genes of cellular suicide.

Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL.

Preclinical studies to predict the disposition of Apo2L/tumor necrosis factorrelated apoptosis-inducing ligand in humans: characterization of in vivo efficacy, pharmacokinetics, and safety. J Pharmacol Exp Ther

Regulation of tumour necrosis factor-related apoptosisinducing ligand (TRAIL) and TRAIL receptor expression in human neutrophils. Immunology

Repression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but not its receptors during oral cancer progression.

Role of Fas ligand expression in promoting escape from immune rejection in a spontaneous tumor model.

Role of tumor necrosis factor-related apoptosis-inducing ligand in interferon-induced apoptosis in human bladder cancer cells. Cancer Res

Safety and antitumor activity of recombinant soluble

The novel receptor TRAIL-R4 induces NFkappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain. Immunity

The receptor for the cytotoxic ligand TRAIL. Science

Tissue distribution of the death ligand TRAIL and its receptors.

TRAIL death receptor-4 expression positively correlates with the tumor grade in breast cancer patients with invasive ductal carcinoma.

Tumor suppressor IRF-1 mediates retinoid and interferon anticancer signaling to death ligand TRAIL.

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med

http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3284069

TRAIL protein expression in breast cancer cells correlates with nuclear grade

Abstract

Similar works

Full text

Available Versions

Crossref